StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM)

StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM) in a report issued on Friday. The firm set a “hold” rating on the biotechnology company’s stock.

Pulmatrix Trading Up 1.5 %

Shares of PULM stock opened at $6.00 on Friday. Pulmatrix has a 1-year low of $1.55 and a 1-year high of $8.44. The stock has a market cap of $21.91 million, a price-to-earnings ratio of -2.27 and a beta of 1.54. The stock has a 50-day moving average of $4.28 and a 200-day moving average of $2.83.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.